- Home
- ADAP vs CPHC Comparison
ADAP vs CPHC Comparison
Compare ADAP & CPHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- CPHC
- Stock Information
- Founded
- ADAP 2008
- CPHC 1994
- Country
- ADAP United Kingdom
- CPHC United States
- Employees
- ADAP N/A
- CPHC N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- CPHC Services-Misc. Amusement & Recreation
- Sector
- ADAP Health Care
- CPHC Consumer Discretionary
- Exchange
- ADAP Nasdaq
- CPHC Nasdaq
- Market Cap
- ADAP 75.5M
- CPHC 89.8M
- IPO Year
- ADAP 2015
- CPHC 1994
- Fundamental
- Price
- ADAP $0.25
- CPHC $18.90
- Analyst Decision
- ADAP Buy
- CPHC
- Analyst Count
- ADAP 6
- CPHC 0
- Target Price
- ADAP $1.52
- CPHC N/A
- AVG Volume (30 Days)
- ADAP 595.5K
- CPHC 6.2K
- Earning Date
- ADAP 08-11-2025
- CPHC 08-07-2025
- Dividend Yield
- ADAP N/A
- CPHC 1.48%
- EPS Growth
- ADAP N/A
- CPHC N/A
- EPS
- ADAP N/A
- CPHC 0.16
- Revenue
- ADAP $179,639,000.00
- CPHC $60,605,931.00
- Revenue This Year
- ADAP N/A
- CPHC N/A
- Revenue Next Year
- ADAP $35.48
- CPHC N/A
- P/E Ratio
- ADAP N/A
- CPHC $117.29
- Revenue Growth
- ADAP 878.53
- CPHC N/A
- 52 Week Low
- ADAP $0.20
- CPHC $16.75
- 52 Week High
- ADAP $1.48
- CPHC $22.96
- Technical
- Relative Strength Index (RSI)
- ADAP 42.09
- CPHC 69.49
- Support Level
- ADAP $0.24
- CPHC $16.90
- Resistance Level
- ADAP $0.27
- CPHC $17.20
- Average True Range (ATR)
- ADAP 0.02
- CPHC 0.39
- MACD
- ADAP -0.00
- CPHC 0.16
- Stochastic Oscillator
- ADAP 23.57
- CPHC 78.47
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.
About CPHC Canterbury Park Holding Corporation 'New'
Canterbury Park Holding Corp is in the business of pari-mutuel wagering on horse races and unbanked card games at its canterbury park racetrack and card casino facility in Minnesota. The company has four operating segments. The horse racing segment represents pari-mutuel wagering operations on simulcast and lives horse races; the Casino segment represents unbanked card operations; the food and beverage segment includes concessions, catering, and events services provided at the Racetrack; and the development segment represents its real estate development operations. The firm generates a majority of its revenue from the Casino segment.